Cussenot O - Search Results

1

Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.

Xylinas E, Drouin SJ, Comperat E, Vaessen C, Renard-Penna R, Misrai V, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Roupret M. Xylinas E, et al. Among authors: cussenot o. BJU Int. 2009 May;103(9):1173-8; discussion 1178. doi: 10.1111/j.1464-410X.2008.08208.x. Epub 2008 Nov 25. BJU Int. 2009. PMID: 19040530

2

Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.

Azzouzi AR, Valeri A, Cormier L, Fournier G, Mangin P, Cussenot O. Azzouzi AR, et al. Among authors: cussenot o. Urology. 2003 Jun;61(6):1193-7. doi: 10.1016/s0090-4295(03)00033-5. Urology. 2003. PMID: 12809896

3

High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.

Valeri A, Fromont G, Sakr W, Azzouzi R, Dey J, Chantrel-Groussard K, Latil A, Berthon P, Cussenot O, Pontes JE, Cher ML. Valeri A, et al. Among authors: cussenot o. Urol Oncol. 2005 Mar-Apr;23(2):87-92. doi: 10.1016/j.urolonc.2004.08.015. Urol Oncol. 2005. PMID: 15869992

4

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421

5

[Transitional cell carcinoma of the upper urinary tract new concepts in management].

Rouprêt M, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Presse Med. 2005 Apr 23;34(8):601-7. doi: 10.1016/s0755-4982(05)83989-2. Presse Med. 2005. PMID: 15962502 Review. French.

6

Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma.

Rouprêt M, Coulet F, Azzouzi AR, Fromont G, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. BJU Int. 2005 Jul;96(1):149-51. doi: 10.1111/j.1464-410X.2005.05585.x. BJU Int. 2005. PMID: 15963139

7

Microsatellite instability and transitional cell carcinoma of the upper urinary tract.

Rouprêt M, Azzouzi AR, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. BJU Int. 2005 Sep;96(4):489-92. doi: 10.1111/j.1464-410X.2005.05671.x. BJU Int. 2005. PMID: 16104897 Review. No abstract available.

8

Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O. Fromont G, et al. Among authors: cussenot o. Eur Urol. 2005 Nov;48(5):764-70. doi: 10.1016/j.eururo.2005.07.005. Epub 2005 Aug 1. Eur Urol. 2005. PMID: 16126329

9

Genetic susceptibility to prostate cancer.

Cancel-Tassin G, Cussenot O. Cancel-Tassin G, et al. Among authors: cussenot o. BJU Int. 2005 Dec;96(9):1380-5. doi: 10.1111/j.1464-410X.2005.05836.x. BJU Int. 2005. PMID: 16287462 Review. No abstract available.

10

Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.

Rouprêt M, Fromont G, Bitker MO, Gattegno B, Vallancien G, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Urology. 2006 May;67(5):1028-32. doi: 10.1016/j.urology.2005.11.035. Urology. 2006. PMID: 16698363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters